Evans syndrome during pembrolizumab therapy for upper urinary tract cancer.
Shota KakitaTomohiro MatsuoMasaharu OhkiAyaka TsuchiyamaTakuji YasudaHiromi NakanishiKensuke MitsunariKojiro OhbaRyoichi ImamuraPublished in: IJU case reports (2023)
This report highlights the potential risk of Evans syndrome associated with immune checkpoint inhibitor treatment. Clinicians should be aware of this possibility and consider early intervention with corticosteroids.